Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 407.65
+6.25 (1.56%)
Aug 4, 2025, 2:30 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 24.59 billion as of August 1, 2025. Its market cap has increased by 192.29% in one year.
Market Cap
24.59B
Enterprise Value
23.67B
Revenue
5.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
407.65
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 24.59B, an increase of 16.66%. That is a compound annual growth rate of 0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 24.59B | -4.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | 14.67B | 82.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Mankind Pharma | 1,059.19B |
| Apollo Hospitals Enterprise | 1,057.03B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |